<p>The mRNA levels of <i>SNAIL1</i>, <i>SLUG</i>, <i>TWIST1</i>, and <i>SIP1</i> were assessed in MDA-MB-231 (A) and HCC-1954 (B) cells at 8, 16 and 24 h of DHMEQ treatment. NF-κB/p65 inhibition was evaluated at protein levels by western blot assay at 16 and 24 h of DHMEQ treatment. Ponceau staining was used as a loading control. Ctrl: control. The data were expressed as the mean ± SD. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001.</p
(A, B) Human (late outgrowth) EPCs were pretreated with Gö6976 (a PKCα inhibitor), SB203580 (a p38 i...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...
<p>(A) MDA-MB-231 cells were transfected with <i>si</i>RNA against NF-κBp65 for 6 hours. As a negati...
<p>A) Inhibition of NF-κB/p65 translocation reduces the expression of EMT-transcription factors that...
<p>(A) Western blot analysis of levels of indicated proteins in PANC-1 cells transduced with pcDNA3....
<p>After treatment with PDTC for 24(<b>A, B</b>) western blotting and (<b>C</b>) Real time RT-PCR wa...
<p>Cells were pretreated with 100 μM TA or 0.01% DMSO for 30 minutes along with an uninfected and un...
<p>(A) HCT116 cells were treated with or without TNFα (20 ng/ml) for 4 days. Cell morphological chan...
<p>(A) pcDNA-Snail (Snail) or control vector pcDNA-3.1 (Vector) were expressed in HCT116 cells for 4...
<p>(A–D) NMuMG cells transfected with control siRNA or ShcA siRNA (siShc-a) were treated or not with...
<p>(A) Kinetics of IκBα degradation and increase in phosphorylation of p65 at serine 536. After veh,...
<p>Relative mRNA levels of (A) E-cadherin (epithelial marker), (B) N-cadherin (mesenchymal marker), ...
<p>(A,B) The cells were treated with PMBPs (0, 5, 10, 25 μg/ml) for 24 h. Cell lysates were prepared...
<p>Cells were pre-treated with 50 μM DMY for 1 h, then with LPS treatment for 2, 4, and 8 h. Western...
<p>(A) Cells were either untreated or pretreated with 2.5 µM As<sub>2</sub>O<sub>3</sub> for 6 hours...
(A, B) Human (late outgrowth) EPCs were pretreated with Gö6976 (a PKCα inhibitor), SB203580 (a p38 i...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...
<p>(A) MDA-MB-231 cells were transfected with <i>si</i>RNA against NF-κBp65 for 6 hours. As a negati...
<p>A) Inhibition of NF-κB/p65 translocation reduces the expression of EMT-transcription factors that...
<p>(A) Western blot analysis of levels of indicated proteins in PANC-1 cells transduced with pcDNA3....
<p>After treatment with PDTC for 24(<b>A, B</b>) western blotting and (<b>C</b>) Real time RT-PCR wa...
<p>Cells were pretreated with 100 μM TA or 0.01% DMSO for 30 minutes along with an uninfected and un...
<p>(A) HCT116 cells were treated with or without TNFα (20 ng/ml) for 4 days. Cell morphological chan...
<p>(A) pcDNA-Snail (Snail) or control vector pcDNA-3.1 (Vector) were expressed in HCT116 cells for 4...
<p>(A–D) NMuMG cells transfected with control siRNA or ShcA siRNA (siShc-a) were treated or not with...
<p>(A) Kinetics of IκBα degradation and increase in phosphorylation of p65 at serine 536. After veh,...
<p>Relative mRNA levels of (A) E-cadherin (epithelial marker), (B) N-cadherin (mesenchymal marker), ...
<p>(A,B) The cells were treated with PMBPs (0, 5, 10, 25 μg/ml) for 24 h. Cell lysates were prepared...
<p>Cells were pre-treated with 50 μM DMY for 1 h, then with LPS treatment for 2, 4, and 8 h. Western...
<p>(A) Cells were either untreated or pretreated with 2.5 µM As<sub>2</sub>O<sub>3</sub> for 6 hours...
(A, B) Human (late outgrowth) EPCs were pretreated with Gö6976 (a PKCα inhibitor), SB203580 (a p38 i...
<p>A: Cellular localization of p65 was analyzed by immunofluorescence staining. HaCaT cells were pre...
<p>(A) MDA-MB-231 cells were transfected with <i>si</i>RNA against NF-κBp65 for 6 hours. As a negati...